1. Identification of Master Regulators Driving Disease Progression, Relapse, and Drug Resistance in Lung Adenocarcinoma
   Qiong Xu et al, 2022, Frontiers in Bioinformatics CrossRef
2. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
   Ilias P. Nikas et al, 2019, Cells CrossRef
3. SRPKs: a promising therapeutic target in cancer
   Muhammad Tufail et al, 2023, Clinical and Experimental Medicine CrossRef
4. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
   William P. Duggan et al, 2022, Molecular and Cellular Biochemistry CrossRef
5. SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms
   Ledong Wan et al, 2022, Genes CrossRef
6. Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells
   Gongli Cai et al, 2024, Communications Chemistry CrossRef
7. Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma
   Gabriela Alves Moreira et al, 2018, Toxicology and Applied Pharmacology CrossRef
8. Function of serine/arginine-rich splicing factors in hematopoiesis and hematopoietic malignancies
   Huifang Zhang et al, 2024, Cancer Cell International CrossRef
9. Therapeutic targeting of TGF‐β in lung cancer
   Sajjad Aftabi et al, 2024, The FEBS Journal CrossRef
10. Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
    Anthony J. Murphy et al, 2022, Frontiers in Oncology CrossRef
11. N6-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing
    Anqi Wang et al, 2024, Cellular & Molecular Biology Letters CrossRef
12. Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention
    Mitesh Patel et al, 2019, Molecular Biology Reports CrossRef
13. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma
    Zhanfei Dong et al, 2022, Bioengineered CrossRef